Showing results (21-30 of 130) with videos related to
Sort By:
Pageof 13
Pharmacoeconomics|January 15, 2004
Cost-effective strategies in the prevention of diabetic nephropathyJonathan D Rippin, Anthony H Barnett, Stephen C BainAtherosclerosis|July 22, 2008
The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular diseaseJeffrey W Stephens, Manish P Khanolkar, Stephen C BainTouchreviews in Endocrinology|August 17, 2022
Glucagon-like Peptide-1 Receptor Analogues for the Treatment of ObesityDavid M Williams, Matthew Staff, Stephen C Bain, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2011
Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy TrialMarc Evans, Stephen C Bain, Simon Hogan, et al.Plos One|April 22, 2016
Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor InternalisationAiysha Thompson, Jeffrey W Stephens, Stephen C Bain, et al.Diabetes, Obesity & Metabolism|September 19, 2018
Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A reviewStephen C Bain, Michael A Klufas, Allen Ho, et al.European Journal of Sport Science|September 28, 2024
Continuous measurement of interstitial glycaemia in professional female UCI world tour cyclists undertaking a 9-day cycle training campRoss Hamilton, Olivia M McCarthy, Stephen C Bain, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 27, 2018
Efficacy and Safety of IDegAsp Versus BIAsp 30, Both Twice Daily, in Elderly Patients with Type 2 Diabetes: Post Hoc Analysis of Two Phase 3 Randomized Controlled BOOST TrialsGreg Fulcher, Roopa Mehta, Edmond G Fita, et al.Current Diabetes Reports|April 12, 2007
Gene discovery in diabetic nephropathyDavid A Savage, Stephen C Bain, Amy Jayne McKnight, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 26, 2021
Glucagon-Like Peptide 1 Receptor Agonist Usage in Type 2 Diabetes in Primary Care for the UK and Beyond: A Narrative ReviewKevin Fernando, Stephen C Bain, Patrick Holmes, et al.Pageof 13